Stablecoin Development Corp （SDEV）
$3.29 +109.55% (MktCap: 166.53M)
wow.qtsky.com/stocksearch/SDEV
Bio-Key International Inc （BKYI）
$3.12 +85.71% (MktCap: 4.48M)
wow.qtsky.com/stocksearch/BKYI
Decent Holding Inc （DXST）
$3.04 +55.90% (MktCap: 5.52M)
wow.qtsky.com/stocksearch/DXST
SoundThinking Inc （SSTI）
$8.21 +50.09% (MktCap: 108.08M)
wow.qtsky.com/stocksearch/SSTI
Masonglory Ltd （MSGY）
$4.44 +41.85% (MktCap: 9.4M)
wow.qtsky.com/stocksearch/MSGY
Sangoma Technologies Corp （SANG）
$4.93 +37.33% (MktCap: 164.07M)
wow.qtsky.com/stocksearch/SANG
Bgin Blockchain Ltd （BGIN）
$2.57 +34.78% (MktCap: 290.76M)
wow.qtsky.com/stocksearch/BGIN
Profusa Inc （PFSA）
$2.27 +34.32% (MktCap: 1.37M)
wow.qtsky.com/stocksearch/PFSA
Iovance Biotherapeutics Inc （IOVA）
$14.45 +31.48% (MktCap: 6.55B)
wow.qtsky.com/stocksearch/IOVA
SVRN Inc （SVRN）
$67.33 +29.34% (MktCap: 126.3M)
wow.qtsky.com/stocksearch/SVRN
========================
Stablecoin Development Corp (SDEV)$3.29+109.55%
wow.qtsky.com/stocksearch/SDEV
SDEV (Stablecoin Development Corporation) is experiencing significant volatility and a notable price surge today, primarily driven by intense speculative momentum trading and bullish sentiment surrounding its stablecoin infrastructure, rather than strong immediate financial results or a clear short squeeze. The stock has been on a multi-week "breakout" run, ripping from below $0.90 in early September to recent highs near $1.83, and further spiking today (September 29, 2026) to $3.20, marking a 15.92% increase in the past 24 hours on exceptionally heavy volume exceeding 161 million shares, far above its average.
Despite this price action, SDEV's fundamentals remain weak; its latest quarterly report (ending June 30, 2026) showed minimal revenue of approximately $2.2 million and a substantial net loss of around $41.1 million, indicating the company is actively burning cash to build its business. However, its balance sheet is remarkably strong for a speculative small-cap, featuring high liquidity and minimal debt, which provides a long "runway" and attracts high-risk traders. The rally is largely fueled by traders "zeroing in on volatile breakout" patterns and a general "bullish sentiment on its expanding stablecoin infrastructure" or "regulatory clarity," creating a "story versus numbers" setup where price action and sentiment outweigh current financials. While short interest exists at 2.81% of the float, the primary driver appears to be speculative buying and technical breakouts rather than a forced short squeeze.
========================
Bio-Key International Inc (BKYI)$3.12+85.71%
wow.qtsky.com/stocksearch/BKYI
BIO-key International (BKYI) is experiencing a significant surge today, primarily driven by two recent and impactful positive developments. The most immediate catalyst is the announcement of a strategic partnership with Dubai-based Al Majlis Group to expand identity security solutions across government and private sectors in the UAE and Saudi Arabia. This partnership is seen as a crucial step for BIO-key to penetrate new, high-growth markets by leveraging Al Majlis Group's regional expertise and government relations.
Additionally, the stock is benefiting from its recent (six days ago) reception of Full Certification from the FIDO Alliance for its Passkey:YOU™ authenticator. This certification validates BIO-key's passwordless authentication solution, positioning it for broader enterprise adoption and new use cases, including those related to agentic AI authenticated controls, thereby significantly expanding its total addressable market.
While the company's Q2 2026 earnings showed improved revenue and reduced net loss, BIO-key remains unprofitable and exhibits negative cash flow, typical of a growth-oriented, speculative small-cap technology firm. Short interest has decreased recently, suggesting today's rally is largely fueled by new buying interest following these material positive news events, rather than a short squeeze. The company has a long-standing claim of securing access for over 40 million users, providing a foundational context for its market presence.
========================
Decent Holding Inc (DXST)$3.04+55.90%
wow.qtsky.com/stocksearch/DXST
Decent Holding (NASDAQ: DXST) is experiencing significant volatility today, September 29, 2026, primarily driven by the launch of its AI-powered in-home senior care service. The company announced today that its SunCare senior care business has officially launched an RMB 500-per-month AI-powered in-home senior care service, backed by a strategic collaboration with Ruilan International and leveraging an existing base of approximately 200,000 estimated paid members. This positive development in its rapidly expanding senior care segment has acted as a strong catalyst, leading to the substantial price fluctuation and exceptionally high trading volume seen today.
The stock traded between $1.99 and $5.70, demonstrating a surge of over 44.9% from its low, with trading volume reaching approximately 39.42 million shares, significantly higher than its average daily volume of 35.78 thousand. While an SEC filing on September 22, 2026, mentioned a unit IPO with warrants and no minimum, which could contribute to market attention, the direct cause of today's sharp movement is the commercial rollout of the new AI senior care service. Given the low short interest, with "days to cover" ranging from 1.00 to 2.12 days, a short squeeze is not indicated as the primary reason for this volatility. The company's relatively small market capitalization and history of significant price swings, including a 1:25 reverse stock split in March 2026, amplify the stock's reaction to major news.
========================
SoundThinking Inc (SSTI)$8.21+50.09%
wow.qtsky.com/stocksearch/SSTI
SoundThinking Inc. (NASDAQ: SSTI) experienced a significant surge in its stock price today, primarily driven by the announcement of a definitive merger agreement. Private equity firm Transom Capital Group will acquire SoundThinking through a tender offer. The deal offers SoundThinking shareholders $8.00 per share in cash, alongside one non-transferable Contingent Value Right (CVR) potentially worth up to an additional $3.00 per share, bringing the total potential consideration to $11.00 per share.
This upfront cash consideration of $8.00 per share represents a substantial 46% premium over SoundThinking's closing stock price on September 28, 2026, the day before the announcement. Should the maximum CVR payment be achieved, the aggregate consideration would represent an impressive 101% premium. The news prompted SSTI shares to trade over 50% higher today. The transaction has received unanimous approval from SoundThinking's Board and is anticipated to finalize in the fourth quarter of 2026, subject to customary closing conditions. Shareholders representing approximately 33% of outstanding common stock have already agreed to tender their shares, and upon completion, SoundThinking will transition to a private entity. The CVRs are contingent on specific revenue targets for SoundThinking's ShotSpotter and SafePointe products in 2027.
========================
Masonglory Ltd (MSGY)$4.44+41.85%
wow.qtsky.com/stocksearch/MSGY
Masonglory (MSGY) has experienced dramatic volatility, including a significant surge and subsequent sharp pullback, primarily driven by its micro-cap status, a recent strategic acquisition, and related financing. The catalyst for this severe fluctuation was the company's announcement of a US$1.0 million private placement, intended to fund the "continued acquisition of equity interests in Beta Beteiligungs und Besitz GmbH," an Austrian distributor of bathtubs, hot tubs, and swim spas in Continental Europe. This news directly corresponds to the reference headline.
Initially, the market reacted positively to Masonglory's strategic diversification beyond its Hong Kong-based wet trades construction business into the European hot tub market. Given MSGY's low float and small market capitalization (around $6.63M - $17.11M), this positive sentiment quickly fueled a "parabolic spike" on September 25, 2026, with the stock soaring from approximately $2 to an intraday high of $11.42. This rapid ascent also likely triggered a "short squeeze," as aggressive day traders piled in and short sellers were forced to cover their positions, further amplifying the upward momentum.
However, the subsequent sharp correction and continued intraday whipsaws are attributable to profit-taking by short-term traders and, crucially, dilution concerns arising from the private placement. The issuance of 667,000 new Class A ordinary shares at just US$1.50 each (with warrants exercisable at $1.10 and $1.30) is significantly below the stock's recent trading highs. This dilution, coupled with the speculative nature of a low-float stock and its tiny book value ($0.21 per share), created a ceiling for the price and incentivized quick profit-taking, leading to a rapid unwinding of gains. The stock's current behavior is a classic example of momentum-driven trading in a thinly traded micro-cap, where price action often overshadows fundamental value.
========================
Sangoma Technologies Corp (SANG)$4.93+37.33%
wow.qtsky.com/stocksearch/SANG
The news headline "Alere Names James Hinrichs EVP And CFO, Effective April 6 - Quick Facts" is outdated and irrelevant to the stock code SANG. Alere Inc. (ALR) was acquired by Abbott Laboratories (ABT) on October 3, 2017, rendering any news prior to that acquisition historical and unrelated to current market movements.
The stock code SANG refers to Sangoma Technologies Corporation, which has indeed experienced significant volatility today. The primary reason for today's substantial price surge is the announcement that Sangoma Technologies has agreed to be acquired by BRC Group Holdings. This take-private deal values Sangoma at an implied US$5.225 per share, representing a premium of 47–51% over its recent trading price. Prior to the announcement, SANG closed at $3.59 on September 28, 2026, and today's trading has seen its price around $4.90–$5.07, reflecting this significant premium.
Shareholders are set to receive US$4.925 in cash plus a fractional share of BRC (RILY) for each Sangoma share. This buyout news has effectively backstopped the stock's price, overshadowing recent weak Q4 earnings that included a larger-than-expected loss, a goodwill impairment, and an inventory write-down. The market is now focused on the arbitrage spread between the current price and the deal value, as well as the progress of the acquisition, which is anticipated to close by early 2027 pending various approvals.
========================
Bgin Blockchain Ltd (BGIN)$2.57+34.78%
wow.qtsky.com/stocksearch/BGIN
BGIN Blockchain Ltd. (NASDAQ: BGIN) has experienced significant recent volatility, primarily driven by its disappointing financial performance. On September 25, 2026, the company reported a steep decline in its first-half 2026 revenue, falling to US$7.4 million from US$47.7 million a year earlier, alongside persistent net losses of US$25.6 million. This sharp deterioration in core business metrics is the fundamental cause for substantial market concern and downward pressure on the stock.
Additionally, the company's invocation of Nasdaq Rule 5615 on September 15, 2026, to use home-country (Cayman Islands) governance practices, specifically exempting it from Rules 5620 (annual meetings) and 5635 (shareholder approval for certain equity-compensation arrangements), further influences investor sentiment. While legally permissible for foreign private issuers, opting for less stringent governance standards compared to typical Nasdaq requirements can be perceived negatively, raising questions about corporate transparency and shareholder protections. This contributes to investor uncertainty and can amplify price movements.
Low short interest, recorded at 0.01% as of August 31, 2026, with a days to cover ratio of 1.59 days, indicates that a short squeeze is not a material factor in any recent large price fluctuations for BGIN. Therefore, the severe revenue drop and ongoing losses, coupled with governance concerns, are the core drivers of BGIN's recent market instability.
========================
Profusa Inc (PFSA)$2.27+34.32%
wow.qtsky.com/stocksearch/PFSA
Profusa (PFSA) experienced a significant decline today, with its stock price decreasing by over 22% in the past 24 hours. This sharp drop comes despite a seemingly positive announcement on September 24, 2026, titled "Profusa Announces Significant Progress towards Lumee Oxygen Platform CE Mark with ISO 13485 certification Expected in Early October."
The core reason for today's volatility and substantial downtrend lies in a combination of factors. Firstly, while the September 24th news indicated a positive decision from GMED regarding the ISO 13485 quality management system certification, it explicitly clarified that this is a *step towards* the Lumee Oxygen Platform's CE Mark, and *further Medical Device Regulation (MDR) conformity assessment activities* are still required. The market likely initially reacted positively to the "progress" headline but has since re-evaluated the actual implications, realizing the full CE Mark approval is not yet assured and its timing remains uncertain.
Secondly, and more critically, Profusa's underlying financial fundamentals are extremely weak. The company operates as a micro-cap with a market capitalization between $1.32 million and $1.84 million. It has reported consistent net losses, maintains a negative earnings per share, and carries a "Going Concern" warning, indicating significant doubts about its ability to continue operations. Despite recent efforts to regain Nasdaq compliance, the company remains under a one-year watch period. The stock has plummeted by approximately 99.9% over the past 12 months, including multiple reverse stock splits.
Therefore, today's significant decline is a reflection of investors recalibrating expectations after the regulatory update, coupled with pervasive concerns about the company's severe financial distress and high inherent volatility. The "progress" on CE Mark, while a necessary milestone, is insufficient to counteract these profound fundamental weaknesses, leading to continued selling pressure and profit-taking.
========================
Iovance Biotherapeutics Inc (IOVA)$14.45+31.48%
wow.qtsky.com/stocksearch/IOVA
Iovance Biotherapeutics (IOVA) experienced a significant upward surge today, September 29, 2026, with shares jumping over 25% and reaching a two-year high. This substantial volatility was primarily driven by the company's announcement before market open that it was sharply raising its full-year 2026 revenue guidance to between $410 million and $420 million. This revised outlook significantly surpasses both the prior forecast of $350 million-$370 million and the analyst consensus estimate of approximately $403 million.
The company attributed this improved guidance to robust and accelerating U.S. demand for its key cancer therapies, Amtagvi (lifileucel) and Proleukin. Amtagvi, as the first FDA-approved tumor-infiltrating lymphocyte (TIL) therapy for advanced melanoma, has shown strong commercial traction. Furthermore, prominent analyst firms like Barclays and Goldman Sachs reacted by raising their price targets and reiterating "Buy" ratings, citing the successful Amtagvi launch and its potential in new indications. While short interest remains notable, the immediate and direct catalyst for today's sharp appreciation is the unexpectedly strong revenue guidance and the subsequent positive analyst endorsement, indicating robust market confidence in Iovance's commercial execution.
========================
SVRN Inc (SVRN)$67.33+29.34%
wow.qtsky.com/stocksearch/SVRN
SVRN (NASDAQ: SVRN) is experiencing significant upward volatility today, with shares moving up over 12% in pre-market trading and continuing to show strong gains throughout the day. This substantial movement is primarily driven by the market's ongoing positive reaction to the company's recently completed corporate transformation. Formerly OceanPal Inc., SVRN has fully pivoted from a traditional cargo shipping business to a digital asset treasury focused on the NEAR Protocol.
The company finalized this strategic shift on August 27, 2026, officially changing its legal name to SVRN, Inc. and launching a public dashboard to provide transparent tracking of its digital asset holdings. SVRN now boasts a substantial treasury of over 55.5 million NEAR tokens, positioning itself as the only publicly traded entity with such a significant NEAR-focused digital asset portfolio. This transformation was initiated with a $120 million private placement in partnership with the NEAR Foundation in October 2025. The current rally is indicative of strong speculative interest and investor optimism surrounding this new cryptocurrency-centric business model, especially given reports of NEAR Protocol tokens themselves experiencing significant recent gains. While the company has reported net losses in previous fiscal periods, the market is clearly prioritizing the potential upside from its digital asset strategy.
========================
For daily analysis of top US stock market losers visit:
https://bigmovewhy.qtsky.com/us-stocks
--------------------------------------------------------
BigMoveWhy-BMW is powered by WOW!StockSearch
Tech Development by QTsky (Build your own tools)
https://wow.qtsky.com
